EMEA-001742-PIP02-16
Key facts
| Active substance |
Derivative of 4H-pyrazolo[3,4-d]pyrimidin-4-one
|
| Therapeutic area |
Psychiatry
|
| Decision number |
P/0338/2016
|
| PIP number |
EMEA-001742-PIP02-16
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Prevention of psychosis
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Boehringer Ingelheim International GmbH
Tel. +49 6132 778271 |
| Decision type |
RP: decision refers to a refusal on a proposed Paediatric Investigation Plan
|